Fraley; Mark E.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Fraley; Mark E..The latest application filed is for "piperidinone carboxamide azaindane cgrp receptor antagonists".
Company Profile
4.68.73
- Fraley; Mark E. - North Wales PA
- FRALEY; Mark E. - West Point PA US
- Fraley, Mark E - North Wales PA
Patent Activity
| Patent | Date |
|---|---|
| 3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors Grant 11,066,396 - Walji , et al. July 20, 2 | 2021-07-20 |
| Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20210008055 - Bell; Ian M. ; et al. | 2021-01-14 |
| Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20190275024 - Bell; Ian M. ; et al. | 2019-09-12 |
| 3-aryl- Heteroaryl Substituted 5-trifluoromethyl Oxadiazoles As Histonedeacetylase 6 (hdac6) Inhibitors App 20190185462 - Walji; Abbas ; et al. | 2019-06-20 |
| Piperidinone carboxamide azaindane CGRP receptor antagonists Grant 10,272,077 - Bell , et al. | 2019-04-30 |
| Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20180092900 - Bell; Ian M. ; et al. | 2018-04-05 |
| TrKA kinase inhibitors, compositions and methods thereof Grant 9,914,736 - Mitchell , et al. March 13, 2 | 2018-03-13 |
| TRKA kinase inhibitors, compositions and methods thereof Grant 9,862,716 - Mitchell , et al. January 9, 2 | 2018-01-09 |
| Piperidinone carboxamide azaindane CGRP receptor antagonists Grant 9,833,448 - Bell , et al. December 5, 2 | 2017-12-05 |
| TrkA kinase inhibitors, compositions and methods thereof Grant 9,815,846 - Mitchell , et al. November 14, 2 | 2017-11-14 |
| TrKA Kinase Inhibitors, Compositions and Methods Thereof App 20170158698 - Mitchell; Helen ; et al. | 2017-06-08 |
| Trka Kinase Inhibitors, Compositions And Methods Thereof App 20170114056 - Mitchell; Helen ; et al. | 2017-04-27 |
| Trka Kinase Inhibitors, Compositions And Methods Thereof App 20170114071 - Mitchell; Helen ; et al. | 2017-04-27 |
| Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20170027925 - Bell; Ian M. ; et al. | 2017-02-02 |
| Piperidinone carboxamide azaindane CGRP receptor antagonists Grant 9,499,545 - Bell , et al. November 22, 2 | 2016-11-22 |
| Positive allosteric modulators of MGLUR2 Grant 8,993,779 - Dudkin , et al. March 31, 2 | 2015-03-31 |
| Ether benzotriazole derivatives Grant 8,975,286 - Dudkin , et al. March 10, 2 | 2015-03-10 |
| Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20150031716 - Bell; Ian M. ; et al. | 2015-01-29 |
| Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20150005330 - Bell; Ian M. ; et al. | 2015-01-01 |
| Piperidinone carboxamide azaindane CGRP receptor antagonists Grant 8,912,210 - Bell , et al. December 16, 2 | 2014-12-16 |
| Piperidinone carboxamide indane CGRP receptor antagonists Grant 8,883,807 - Bell , et al. November 11, 2 | 2014-11-11 |
| Ether benzotriazole derivatives Grant 8,785,481 - Beshore , et al. July 22, 2 | 2014-07-22 |
| Piperidinone carboxamide azaindane CGRP receptor antagonists Grant 8,754,096 - Bell , et al. June 17, 2 | 2014-06-17 |
| AHCY hydrolase inhibitors for treatment of hyper homocysteinemia Grant 8,629,275 - Converso , et al. January 14, 2 | 2014-01-14 |
| Disubstituted azepan orexin receptor antagonists Grant 8,623,863 - Coleman , et al. January 7, 2 | 2014-01-07 |
| Piperidinone Carboxamide Spirohydantoin Cgrp Receptor Antagonists App 20140005214 - Bell; Ian M. ; et al. | 2014-01-02 |
| Piperidinone Carboxamide Indane Cgrp Receptor Antagonists App 20130231358 - Bell; Ian M. ; et al. | 2013-09-05 |
| Piperidinone carboxamide azaindane CGRP receptor antagonists Grant 8,481,556 - Bell , et al. July 9, 2 | 2013-07-09 |
| Positive Allosteric Modulators Of Mglur2 App 20130143880 - Dudkin; Vadim Y. ; et al. | 2013-06-06 |
| Imidizo[1,2-A]pyrazines useful as AHCY hydrolase inhibitors Grant 8,329,697 - Garbaccio , et al. December 11, 2 | 2012-12-11 |
| Ether Benzotriazole Derivatives App 20120149677 - Dudkin; Vadim Y. ; et al. | 2012-06-14 |
| Ether Benzotriazole Derivatives App 20120135977 - Beshore; Douglas C. ; et al. | 2012-05-31 |
| Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20120122900 - Bell; Ian M. ; et al. | 2012-05-17 |
| Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20120122899 - Bell; Ian M. ; et al. | 2012-05-17 |
| Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists App 20120122911 - Bell; Ian M. ; et al. | 2012-05-17 |
| Pyridine Carboxamide orexin Receptor Antagonists App 20110301140 - Bergman; Jeffrey M. ; et al. | 2011-12-08 |
| Mineralocorticoid receptor modulators Grant 8,063,090 - Brandish , et al. November 22, 2 | 2011-11-22 |
| Disubstituted Azepan Orexin Receptor Antagonists App 20110207715 - Cox; Christopher D. ; et al. | 2011-08-25 |
| Pyridine carboxamide orexin receptor antagonists Grant 8,003,797 - Bergman , et al. August 23, 2 | 2011-08-23 |
| Ahcy Hydrolase Inhibitors For Treatment Of Hyper Homocysteinemia App 20110160229 - Converso; Antonella ; et al. | 2011-06-30 |
| Oxazolobenzimidazole Derivatives App 20110124661 - Brnardic; Edward J. ; et al. | 2011-05-26 |
| Oxazolobenzimidazole Derivatives App 20110065669 - Brnardic; Edward J. ; et al. | 2011-03-17 |
| Ahcy Hydrolase Inhibitors For Treatment Of Hyper Homocysteinemia App 20100305135 - Garbaccio; Robert M. ; et al. | 2010-12-02 |
| Mineralocorticoid Receptor Modulators App 20100261765 - Brandish; Philip E. ; et al. | 2010-10-14 |
| Pyridine Carboxamide Orexin Receptor Antagonists App 20100197652 - Bergman; Jeffrey M. ; et al. | 2010-08-05 |
| Mitotic kinesin inhibitors Grant 7,732,472 - Fraley , et al. June 8, 2 | 2010-06-08 |
| Mitotic kinesin inhibitors Grant 7,723,365 - Cox , et al. May 25, 2 | 2010-05-25 |
| Mineralocorticoid Receptor Modulators App 20100069452 - Brandish; Philip E. ; et al. | 2010-03-18 |
| Mitotic kinesin inhibitors Grant 7,632,833 - Bergman , et al. December 15, 2 | 2009-12-15 |
| Mitotic kinesin inhibitors Grant 7,625,912 - Arrington , et al. December 1, 2 | 2009-12-01 |
| Mitotic kinesin inhibitors Grant 7,622,468 - Fraley , et al. November 24, 2 | 2009-11-24 |
| Mitotic kinesin inhibitors Grant 7,622,489 - Fraley , et al. November 24, 2 | 2009-11-24 |
| Mitotic kinesin inhibitors Grant 7,618,971 - Coleman , et al. November 17, 2 | 2009-11-17 |
| Inhibitors of Checkpoint Kinases App 20090258852 - Arrington; Kenneth L. ; et al. | 2009-10-15 |
| Inhibitors of checkpoint kinases App 20090233896 - Arrington; Kenneth L. ; et al. | 2009-09-17 |
| Inhibitors of checkpoint kinases App 20090182001 - Fraley; Mark E. ; et al. | 2009-07-16 |
| Mitotic kinesin inhibitors Grant 7,553,838 - Fraley , et al. June 30, 2 | 2009-06-30 |
| Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors Grant 7,550,470 - Fraley June 23, 2 | 2009-06-23 |
| Inhibitors of checkpoint kinases Grant 7,550,477 - Brnardic , et al. June 23, 2 | 2009-06-23 |
| Inhibitors of checkpoint kinases Grant 7,501,435 - Arrington , et al. March 10, 2 | 2009-03-10 |
| Inhibitors of checkpoint kinases Grant 7,485,649 - Brnardic , et al. February 3, 2 | 2009-02-03 |
| Inhibitors of Checkpoint Kinases App 20090023767 - Brnardic; Edward J. ; et al. | 2009-01-22 |
| Mitotic Kinesin Inhibitors App 20090005418 - Fraley; Mark E. ; et al. | 2009-01-01 |
| Mitotic Kinesin Inhibitors App 20080287414 - Bergman; Jeffrey M. ; et al. | 2008-11-20 |
| Inhibitors of Checkpoint Kinases App 20080280902 - Fraley; Mark E. ; et al. | 2008-11-13 |
| Tyrosine kinase inhibitors App 20080274107 - Fraley; Mark E. ; et al. | 2008-11-06 |
| Inhibitors Of Checkpoint Kinases App 20080214594 - Brnardic; Edward J. ; et al. | 2008-09-04 |
| Mitotic Kinesin Inhibitors App 20080153887 - Cox; Christopher D. ; et al. | 2008-06-26 |
| Substituted thienopyrimidinones as a mitotic kinesin inhibitor Grant 7,378,411 - Fraley , et al. May 27, 2 | 2008-05-27 |
| Inhibitors of Checkpoint Kinases App 20080114016 - Brnardic; Edward J. ; et al. | 2008-05-15 |
| Mitotic kinesin inhibitors Grant 7,348,440 - Arrington , et al. March 25, 2 | 2008-03-25 |
| Prodrugs of mitotic kinesin inhibitors Grant 7,329,762 - Fraley , et al. February 12, 2 | 2008-02-12 |
| Mitotic Kinesin Inhibitors App 20080032980 - Fraley; Mark E. ; et al. | 2008-02-07 |
| Mitotic Kinesin Inhibitors App 20080027058 - Coleman; Paul J. ; et al. | 2008-01-31 |
| Inhibitors of Checkpoint Kinases App 20080004259 - Arrington; Kenneth L. ; et al. | 2008-01-03 |
| Mitotic kinesin inhibitors Grant 7,301,028 - Arrington , et al. November 27, 2 | 2007-11-27 |
| Inhibitors of checkpoint kinases App 20070254879 - Arrington; Kenneth L. ; et al. | 2007-11-01 |
| Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor Grant 7,262,187 - Fraley , et al. August 28, 2 | 2007-08-28 |
| Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic kinesin inhibitor Grant 7,262,186 - Fraley , et al. August 28, 2 | 2007-08-28 |
| Tyrosine kinase inhibitors Grant 7,262,199 - Fraley , et al. August 28, 2 | 2007-08-28 |
| Substituted furopyrimidinones as a mitotic kinesin inhibitors Grant 7,244,723 - Fraley , et al. July 17, 2 | 2007-07-17 |
| Mitotic kinesin inhibitors App 20070149553 - Arrington; Kenneth L. ; et al. | 2007-06-28 |
| Mitotic kinesin inhibitors App 20070129356 - Arrington; Kenneth L. ; et al. | 2007-06-07 |
| Substituted bicyclic pyrimidinones as a mitotic kinesin KSP inhibitors Grant 7,192,949 - Fraley , et al. March 20, 2 | 2007-03-20 |
| Mitotic kinesin inhibitors App 20070060601 - Arrington; Kenneth L. ; et al. | 2007-03-15 |
| Tyrosine kinase inhibitors Grant 7,186,723 - Peckham , et al. March 6, 2 | 2007-03-06 |
| Tyrosine kinase inhibitors Grant 7,169,788 - Arrington , et al. January 30, 2 | 2007-01-30 |
| Tyrosine kinase inhibitors Grant 7,125,888 - Bilodeau , et al. October 24, 2 | 2006-10-24 |
| Tyrosine kinase inhibitors Grant 7,109,204 - Fraley , et al. September 19, 2 | 2006-09-19 |
| Tyrosine kinase inhibitors Grant 7,101,884 - Arrington , et al. September 5, 2 | 2006-09-05 |
| Mitotic kinesin inhibitors App 20060189630 - Fraley; Mark E. ; et al. | 2006-08-24 |
| Tyrosine kinase inhibitors App 20060183755 - Fraley; Mark E. ; et al. | 2006-08-17 |
| Prodrugs of mitotic kinesin inhibitors App 20060135594 - Fraley; Mark E. ; et al. | 2006-06-22 |
| Mitotic kinesin inhibitors Grant 7,060,705 - Fraley , et al. June 13, 2 | 2006-06-13 |
| Mitotic kinesin inhibitors App 20060105997 - Arrington; Kenneth L. ; et al. | 2006-05-18 |
| Tyrosine kinase inhibitors App 20060025426 - Fraley; Mark E. | 2006-02-02 |
| Orally active salts with tyrosine kinase activity Grant 6,960,590 - Fraley , et al. November 1, 2 | 2005-11-01 |
| Mitotic kinesin inhibitors App 20050228003 - Fraley, Mark E ; et al. | 2005-10-13 |
| Mitotic kinesin inhibitors App 20050203110 - Coleman, Paul J. ; et al. | 2005-09-15 |
| Tyrosine kinase inhibitors App 20050176753 - Bilodeau, Mark T. ; et al. | 2005-08-11 |
| Mitotic kinesin inhibitors App 20050176737 - Fraley, Mark E ; et al. | 2005-08-11 |
| Mitotic kinesin inhibitors App 20050171122 - Fraley, Mark E. ; et al. | 2005-08-04 |
| Mitotic kinesin inhibitors App 20050107404 - Fraley, Mark E ; et al. | 2005-05-19 |
| Tyrosine kinase inhibitors App 20050096344 - Fraley, Mark E. ; et al. | 2005-05-05 |
| Tyrosine kinase inhibitors App 20050070546 - Arrington, Kenneth L. ; et al. | 2005-03-31 |
| Mitotic kinesin inhibitors App 20050032817 - Fraley, Mark E ; et al. | 2005-02-10 |
| Mitotic kinesin inhibitors App 20040259826 - Fraley, Mark E. ; et al. | 2004-12-23 |
| Tyrosine kinase inhibitors App 20040235875 - Fraley, Mark E. ; et al. | 2004-11-25 |
| Tyrosine kinase ihnibitors App 20040235826 - Peckham, Jennifer P. ; et al. | 2004-11-25 |
| Tyrosine kinase inhibitors App 20040220216 - Arrington, Kenneth L ; et al. | 2004-11-04 |
| Tyrosine kinase inhibitors Grant 6,794,393 - Fraley , et al. September 21, 2 | 2004-09-21 |
| Tyrosine kinase inhibitors App 20040181066 - Fraley, Mark E. ; et al. | 2004-09-16 |
| Orally active salts with tyrosine kinase activity App 20040002501 - Fraley, Mark E. ; et al. | 2004-01-01 |
| Orally active salts with tyrosine kinase activity Grant 6,656,942 - Fraley , et al. December 2, 2 | 2003-12-02 |
| Tyrosine kinase inhibitors Grant 6,479,512 - Fraley , et al. November 12, 2 | 2002-11-12 |
| Tyrosine kinase inhibitors Grant 6,420,382 - Fraley , et al. July 16, 2 | 2002-07-16 |
| Orally active salts with tyrosine kinase activity App 20020072526 - Fraley, Mark E. ; et al. | 2002-06-13 |
| Tyrosine kinase inhibitors App 20010047007 - Fraley, Mark E. ; et al. | 2001-11-29 |
| Tyrosine kinase inhibitors App 20010044451 - Fraley, Mark E. ; et al. | 2001-11-22 |
| Tyrosine kinase inhibitors Grant 6,313,138 - Fraley , et al. November 6, 2 | 2001-11-06 |
| Tyrosine kinase inhibitors Grant 6,306,874 - Fraley , et al. October 23, 2 | 2001-10-23 |
| Angiogenesis inhibitors Grant 6,265,403 - Fraley , et al. July 24, 2 | 2001-07-24 |
| Tyrosine kinase inhibitors Grant 6,245,759 - Bilodeau , et al. June 12, 2 | 2001-06-12 |
| Angiogenesis inhibitors Grant 6,235,741 - Bilodeau , et al. May 22, 2 | 2001-05-22 |
| Thrombin inhibitors Grant 5,872,138 - Naylor-Olsen , et al. February 16, 1 | 1999-02-16 |
| Thrombin inhibitors Grant 5,792,761 - Fraley , et al. August 11, 1 | 1998-08-11 |
| Pyridinone thrombin inhibitors Grant 5,668,289 - Sanderson , et al. September 16, 1 | 1997-09-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 